Invion

IVX.AX

Tags: AU Healthcare Drug Manufacturers - Specialty & Generic

Invion Limited Price (IVX.AX)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

6,424,407,069

(0.075)%

Market Cap of Invion (IVX.AX)

Market cap:

As of , IVX.AX has a market cap of . This makes IVX.AX the 1227th most valuable company in the AU by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

Invion Limited, a clinical-stage life-sciences company, researches and develops photodynamic therapy for the treatment of various cancers in Australia. The company is developing IVX-PDT, a photosensitizer agent to treat skin cancers, as well as solid cancers, including lung, prostrate, ovarian, and mesothelioma cancers. It has a research and development agreement with Hudson Institute of Medical Research to collaborate on a range of research and development projects for the Photosoft technology for the treatment of a range of cancers; and research agreem... Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $0.1-0.6
Market Cap 9.29M
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Drug Manufacturers - Specialty & Generic

ceo: Mr. Thian Chew
IPO Date: February, 14, 2010
Country: AU
Currency: AUD
Headquaters: Melbourne, VIC
Employees: 8

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: